FdaApplication
ANDA 212513
Identifiers
- fda_app_no: ANDA212513
Properties
| Property | Value |
|---|---|
| applicant_name | BE PHARMACEUTICALS AG |
| application_type | ANDA |
| approval_date | 2019-06-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPTOMYCIN | DAPTOMYCIN | 500MG/VIAL | POWDER;INTRAVENOUS |
1 product